Bachem marks 25 years of DCAT Week membership

Bubendorf, Switzerland: – Peptide technology specialist Bachem AG will again be sending a strong representative team to North America’s premier pharma industry networking event, DCAT Week in 2023, marking a quarter century’s membership of the organization.

Bachem first became a member company of the not-for-profit business development organisation the Drug, Chemical & Associated Technologies Association (DCAT) in 1998 and has been a consistent presence at DCAT Week in New York City ever since.

DCAT Week is far more than a trade show, providing instead a unique, multifaceted week of events that provides unique opportunities for its Member Companies to network, share insights and create collaborative opportunities.

Strong Bachem team

For DCAT 2023, the Bachem Team in New York will be headed by Vice-President and Head of Global Sales, André Casagrande, and will include Senior Director and Head Of Portfolio Generics Eric Bouillet, Group Leaders in Sales Generics, Pascal Hess and Sergey Malashikhin, Director Product Management Tycho Leifels, Head Global Business Development Chris McGee, and Head of Global Strategic Alliances Boris Corpataux.

This year’s DCAT focus for Bachem will include its rapidly expanding capabilities in cGMP therapeutic oligonucleotide development and production, its ‘smart factory’ Industry 4.0  digitally integrated manufacturing vision and its strides towards sustainable green chemistry, all reinforcing its credentials as the world’s leading ‘tides partner.

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

For further information, see www.bachem.com.

About DCAT Week 2023

The Drug, Chemical & Associated Technologies Association (DCAT), founded in 1890, has become North America’s premier business development association for companies that manufacture, distribute or provide services to the pharmaceutical and chemical industries.

DCAT represents the entire spectrum of the pharmaceutical industry—from pharmaceutical, API, and excipient sales and manufacturing to distribution, support technologies and packaging products and services.

Attended by thousands of industry professionals, DCAT Week® and the DCAT Annual Dinner, held each March in New York City, is considered as a premier global event for companies engaged in the biotech and pharmaceutical manufacturing value chains.

DCAT Week 2023 will take place over four days from Monday, March 20, 2023, with its central venue at the Lotte New York Palace in Madison Avenue, New York City. It is expected to attract more than 10,000 attendees, overwhelmingly C-Suite executives and high-level decision makers, representing some 700 companies drawn from more than 50 nations worldwide.

The week will conclude with the 95th DCAT Annual Dinner, again held in the Grand Ballroom of the New York Hilton on the evening of Thursday, March 24, featuring live stand up from Jerry Seinfeld.

The event is organized by DCAT with more information at: https://dcatweek.org

Resources

Click on Bachem at DCAT Week 2023 for more information.
Click on Bachems News to see latest News & Events.